Role of nanobiotechnology in the personalized management of glioblastoma multiforme

Nanomedicine

Volumn 6, Issue 3, 2011, Pages 411-414

  Jain, Kewal K ^a  

^a PharmaBiotech   (Switzerland)

Author keywords

brain tumor; cancer; chemotherapy; drug delivery; glioblastoma multiforme; nanobiotechnology; nanooncology; nanoparticles; personalized medicine

Indexed keywords

CARMUSTINE; CHITOSAN; DENDRIMER; DNA; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; GLYCEROL DERIVATIVE; IRON OXIDE; MACROGOL; MALIC ACID DERIVATIVE; METHACRYLIC ACID DERIVATIVE; NANOPARTICLE; PEPTIDE; POLOXAMER; POLYGLACTIN; POLYSORBATE 80; QUANTUM DOT; SMALL INTERFERING RNA; TRANSFERRIN;

BRAIN TUMOR; CANCER DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; GLIOBLASTOMA; HUMAN; HYDROGEL; HYPERTHERMIC THERAPY; NANOBIOTECHNOLOGY; NANOPROBE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PERSONALIZED MEDICINE; PRIORITY JOURNAL; REVIEW; TUMOR;

BIOTECHNOLOGY; BRAIN NEOPLASMS; DRUG DELIVERY SYSTEMS; GENE THERAPY; GLIOBLASTOMA; HUMANS; HYPERTHERMIA, INDUCED; INDIVIDUALIZED MEDICINE; NANOPARTICLES; NANOTECHNOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 79955615214     PISSN: 17435889     EISSN: None     Source Type: Journal    
DOI: 10.2217/nnm.11.12     Document Type: Review

References (14)

1. Jain KK: Potential of nanobiotechnology in management of glioblastoma multiforme. In:Glioblastoma: Molecular Mechanisms of Pathogenesis and Current Therapeutic StrategiesRay SK (Ed.). Springer, NY, USA, 399-419 (2010).
2. Jain KK: Textbook of Personalized Medicine. Springer, NY, USA (2009).
3. Veiseh O, Sun C, Fang C et al.: Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res. 69, 6200-6207 (2009).
4. Jain KK: Handbook of Biomarkers. Springer, NY, USA (2010).
5. Wang J, Yong WH, Sun Y et al.: Receptor-targeted quantum dots: Fluorescent probes for brain tumor diagnosis. J. Biomed. Opt. 12, 044021 (2007).
6. Ding H, Inoue S, Ljubimov AV et al.: Inhibition of brain tumor growth by intravenous poly(b-l-malic acid) nanobioconjugate with pH-dependent drug release. Proc. Natl Acad. Sci. USA 107, 18143-18148 (2010).
7. Meenach SA, Hilt JZ, Anderson KW: Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy. Acta Biomater. 6, 1039-1046 (2010).
8. Maier-Hauff K, Ulrich F, Nestler D et al.: Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J. Neurooncol. DOI: 10.1007/s11060-010-0389-0 (2010) (Epub ahead of print).
9. Jain KK: Use of nanoparticles for drug delivery in glioblastoma multiforme. Expert Rev. Neurother. 7, 363-372 (2007). (Pubitemid 46623359)
10. Barbu E, Molnàr E, Tsibouklis J, Górecki DC: The potential for nanoparticle-based drug delivery to the brain: Overcoming the blood-brain barrier. Expert Opin. Drug Deliv. 6, 553-565 (2009).
11. Kreuter J, Gelperina S: Use of nanoparticles for cerebral cancer. Tumori 94, 271-277 (2008). (Pubitemid 351838835)
12. Kang CS, Yuan X, Zhong Y et al.: Growth inhibition against intracranial C6 glioma cells by stereotactic delivery of BCNU by controlled release from poly(d,l-lactic acid) nanoparticles. Tech. Cancer Res. Treat. 8, 61-70 (2009).
13. Koppu S, Oh YJ, Edrada-Ebel R et al.: Tumor regression after systemic administration of a novel tumor-targeted gene delivery system carrying a therapeutic plasmid DNA. J. Control. Release 143, 215-221 (2010).
14. Ofek P, Fischer W, Calderón M et al.: In vivo delivery of small interfering RNA to tumors and their vasculature by novel dendritic nanocarriers. FASEB J. 24, 3122-3134 (2010).